ARCO CHEMICAL CO
10-Q, 1995-04-28
INDUSTRIAL ORGANIC CHEMICALS
Previous: FIDELITY INSTITUTIONAL TRUST, NSAR-B, 1995-04-28
Next: NATIONAL REALTY L P, 8-K, 1995-04-28



<PAGE>
 
- -------------------------------------------------------------------------------
  --------------------------------------------------------------------------
     --------------------------------------------------------------------

                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 10-Q
                                  -----------      

          [x]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

                        SECURITIES EXCHANGE ACT OF 1934

                 For the quarterly period ended March 31, 1995
                                        
                 --------------------------------------------

                         Commission file number 1-9678

                     ------------------------------------

                             ARCO Chemical Company
            (Exact name of registrant as specified in its charter)

                                  -----------

                Delaware                               51-0104393
       (State or other jurisdiction of      (I.R.S. Employer Identification No.)
         incorporation or organization)

          3801 West Chester Pike
       Newtown Square, Pennsylvania                    19073-2387
   (Address of principal executive offices)            (Zip Code)

                                  -----------

                                (610) 359-2000
             (Registrant's telephone number, including area code)

                                  -----------

                                Not Applicable
  (Former name, former address and former fiscal year, if changed since last
   report)

                                  -----------       


   Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes  [x]  No ___
                                                     

   Number of shares of Common Stock, $1.00 par value, outstanding as of March
31, 1995: 96,193,359.

    ----------------------------------------------------------------------
  ---------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
 
                        PART I.  FINANCIAL INFORMATION

                Item 1.  ARCO CHEMICAL COMPANY AND SUBSIDIARIES
                 CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

                       CONSOLIDATED STATEMENTS OF INCOME
                 (Millions of Dollars, Except Per Share Data)

<TABLE>
<CAPTION>
                                         Three Months
                                            Ended
                                           March 31,
                                       ----------------
                                        1995      1994
                                        ----      ----
<S>                                    <C>       <C>  
Sales and other operating revenues     $1,141    $ 757
Costs and other operating expenses        844      587
                                       ------    -----
    Gross profit                          297      170
Selling, general and administrative
  expenses                                 64       57
Research and development                   18       17
                                       ------    -----
    Operating income                      215       96
Interest expense                          (22)     (21)
Other income, net                           5        1
                                       ------    -----
    Income before income taxes            198       76
Provision for income taxes                 72       31 
                                       ------    -----
    Net income                         $  126    $  45 
                                       ======    =====
    Earnings per common share          $ 1.31    $ .47 
                                       ======    =====
    Cash dividends paid per common
      share                            $ .625    $.625
                                       ======    =====
 
</TABLE>



                            See accompanying notes.
<PAGE>
 
                             ARCO CHEMICAL COMPANY
                          CONSOLIDATED BALANCE SHEETS
                             (Millions of Dollars)

<TABLE> 
<CAPTION> 
                                        
                                                March 31,     December 31,
                                                  1995           1994
                                                  ----           ----
 
                    ASSETS
<S>                                              <C>          <C>    
Current assets:                                                       
    Cash and cash equivalents                    $  105       $  144  
    Accounts receivable                             693          565  
    Inventories                                     400          397  
    Prepaid expenses and other current assets        40           18  
                                                 ------       ------  
        Total current assets                      1,238        1,124  
Investments and long-term receivables                94           97  
Property, plant and equipment, net                2,279        2,221  
Deferred charges and other assets (net of                             
  accumulated amortization of $257 in 1995      
  and $247 in 1994)                                 366          295  
                                                 ------       ------  
        Total assets                             $3,977       $3,737  
                                                 ======       ======   
 
</TABLE>
                      LIABILITIES AND STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
 
 
Current liabilities:
<S>                                            <C>            <C>
    Notes payable                              $   24         $   23 
    Long-term debt due within one year             17             15 
    Accounts payable                              277            242 
    Taxes payable                                 113             66 
    Other accrued liabilities                     203            199 
                                               ------         ------ 
        Total current liabilities                 634            545 
Long-term debt                                    906            898 
Other liabilities and deferred credits            148            142 
Deferred income taxes                             405            369 
Minority interest                                 118            124 
                                                                     
Stockholders' equity:                                                
    Common stock                                  100            100 
    Additional paid-in capital                    865            864 
    Retained earnings                             798            732 
    Foreign currency translation                  107             70 
    Treasury stock, at cost                      (104)          (107)
                                               ------         ------ 
        Total stockholders' equity              1,766          1,659 
                                               ------         ------ 
                                                                     
        Total liabilities and stockholders'                          
          equity                               $3,977         $3,737 
                                               ======         ======  
 
</TABLE>



                            See accompanying notes.

                                     - 2 -
<PAGE>
 
                             ARCO CHEMICAL COMPANY
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                             (Millions of Dollars)
<TABLE>
<CAPTION>
 
 
                                                    Three Months Ended
                                                        March 31,
                                                   --------------------
                                                        1995      1994
                                                       -----     -----
 <S>                                               <C>           <C> 
 Cash flows from operating activities
     Net income                                        $ 126     $  45
     Adjustments to reconcile net income
       to net cash provided by operating
       activities:
         Depreciation and amortization                    59        57
         Net change in accounts receivable              (101)        8
         Net change in inventories, accounts
           and other payables                             82        21
         Other                                           (32)      (28)
                                                       -----     -----
 
     Net cash provided by operating activities           134       103
                                                       -----     -----
 
 Cash flows from investment activities
     Increase in deferred charges                        (74)        -
     Capital expenditures                                (28)      (34)
     Other                                                 -        21
                                                       -----     -----
 
     Net cash used in investment activities             (102)      (13)
                                                       -----     -----
 
 Cash flows from financing activities
     Dividends paid                                      (60)      (60)
     Net repayments of notes payable                      (1)      (25)
     Repayment of long-term debt                         (14)      (12)
     Other                                                 4         2
                                                       -----     -----
 
     Net cash used in financing activities               (71)      (95)
                                                       -----     -----
 
 Effect of exchange rate changes on cash                   -         -
                                                       -----     -----
 
 Net decrease in cash and cash equivalents               (39)       (5)
 
 Cash and cash equivalents at beginning of year          144        42
                                                       -----     -----
 
 Cash and cash equivalents at end of period            $ 105     $  37
                                                       =====     =====
 
</TABLE>



                            See accompanying notes.

                                     - 3 -
<PAGE>
 
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
                                        

 NOTE A.  Basis of Presentation

          The foregoing financial information is unaudited and has been prepared
 from the records of ARCO Chemical Company (the company).  In the opinion of
 management, the financial information reflects all adjustments (consisting only
 of items of a normal recurring nature) necessary for a fair statement of
 financial position and results of operations in conformity with generally
 accepted accounting principles.  Certain amounts in 1994 have been reclassified
 for comparative purposes.  These interim financial statements should be read in
 conjunction with the consolidated financial statements for the year ended
 December 31, 1994.


 NOTE B.  Business Segment Information

          The following table sets forth certain information concerning the
 company's principal geographic regions for the periods indicated:

<TABLE>
<CAPTION>
 
 
                                        Three Months Ended
                                             March 31,
                                        -----------------------
                                          1995        1994
                                          ----        ----

                                        (Millions of Dollars)
  <S>                                   <C>          <C> 
  Total revenues
    Americas                             $  789      $ 539
    Europe                                  354        211
    Asia Pacific                             58         54
    Elimination of interregional
      sales                                 (60)       (47)
                                         ------      -----
 
        Total                            $1,141      $ 757
                                         ======      =====
 
Pretax earnings
    Americas                             $  180      $  95
    Europe                                   (8)        (9)
    Asia Pacific                              3         (4)
    Corporate                                38         13
    Interest expense                        (22)       (21)
    Equity in net income of
      Asian joint venture                     3          -
    Eliminations                              4          2
                                         ------      -----
 
        Total                            $  198      $  76
                                         ======      =====
 
</TABLE>

 Interregional sales are made at prices approximating current market values.
 Included in pretax earnings are royalty charges made from corporate to the
 regions for the use of company technology.



                                     - 4 -
<PAGE>
 
 NOTE C.  Inventories

          Inventories at March 31, 1995 and December 31, 1994 comprised the
 following categories:

<TABLE>
<CAPTION>
 
                               1995       1994
                               ----       ----
 
                               (Millions of Dollars)
<S>                            <C>        <C> 
Finished goods                 $ 264      $ 272
Work-in-process                   35         35
Raw materials                     59         49
Materials and supplies            42         41
                               -----      -----
 
    Total                      $ 400      $ 397
                               =====      =====
 
</TABLE>

 NOTE D.  Property, Plant and Equipment, Net

          Property, plant and equipment, at cost, and related accumulated
 depreciation at March 31, 1995 and December 31, 1994 were as follows:

<TABLE>
<CAPTION>
 
                                       1995       1994
                                       ----       ----
 
                                       (Millions of Dollars)
<S>                                    <C>        <C>  
Property, plant and equipment          $3,675     $3,524
Less:  accumulated depreciation         1,396      1,303
                                       ------     ------
 
    Total                              $2,279     $2,221
                                       ======     ======
 
</TABLE>

NOTE E.   Contingencies

          The company and its subsidiaries are involved in a number of
lawsuits, all of which have arisen in the ordinary course of the company's
business.  The company is unable to predict the outcome of these matters, but
does not believe, based upon currently available facts, that the ultimate
resolution of such matters will have a material adverse effect on the
consolidated financial statements of the company.

          The company is subject to other loss contingencies pursuant to
 federal, state, local, and foreign environmental laws and regulations.  These
 contingencies  include possible obligations to remove or mitigate the effect on
 the environment of the disposal or release of certain chemical substances at
 various sites.  The company continues to estimate the amount of these costs and
 periodically establishes reserves based on the progress made in determining the
 magnitude, method and timing of the remedial actions that may be required by
 government authorities, and an evaluation of the company's potential liability
 in relation to the liability and financial resources of the other potentially
 responsible parties.

          At March 31, 1995, the company's environmental reserve totaled $49
 million, which reflects the company's latest assessment of potential future
 costs associated with existing sites.  A significant portion of the reserve is
 related to the company's Beaver   Valley (Pennsylvania)  facility.   The
 company and the Pennsylvania  Department of Environmental Resources have agreed


                                     - 5 -
<PAGE>
 
 upon a work plan for testing and remedial process design with regard to
 conditions at the Beaver Valley plant.  The reserve reflects an agreement
 between the company and another responsible party whereby that party has agreed
 to pay for approximately 50 percent of the cost of the remediation at the
 Beaver Valley plant.  The remainder of the reserve is related to six other
 sites for amounts ranging from $1 million to $7 million per site.
 Substantially all amounts accrued are expected to be paid out over the next
 five to ten years.

          The company is currently performing environmental site assessments,
 remedial investigations/feasibility studies, and remediation activities at a
 number of sites under these laws.  The company may in the future be involved in
 additional environmental assessments and cleanups.  As the scope of the
 company's environmental contingencies becomes more clearly defined, it is
 possible that amounts in excess of those already reserved may be necessary.

          Management believes, based upon its past experience and best
 assessment of future events, that these environmental liabilities and costs
 will be determined and incurred over an extended period of time, allowing the
 company to fund such liabilities and costs through its operating cash flow, and
 therefore that the impact of such liabilities and costs would not be material
 in relation to the company's consolidated financial position as of March 31,
 1995.  Depending on the amounts of future operating results, the environmental
 liabilities to be recorded in a given annual or quarterly period may
 potentially result in charges that are material to the results of operations
 for that period.

          The company and Atlantic Richfield Company (ARCO) are parties to an
 agreement whereby the company has indemnified ARCO against certain claims or
 liabilities that ARCO may incur relating to ARCO's former ownership and
 operation of the oxygenates and polystyrenics businesses of the company,
 including liabilities under laws relating to the protection of the environment
 and the workplace and liabilities arising out of certain litigation.  ARCO has
 indemnified the company with respect to claims or liabilities and other matters
 of litigation not related to the assets or businesses reflected in the
 consolidated financial statements.  ARCO has also indemnified the company for
 certain federal, foreign, state, and local taxes that might be assessed upon
 audit of the operations of the company included in its consolidated financial
 statements for periods prior to July 1, 1987.


NOTE F.   Earnings Per Common Share

          Earnings per common share for the three months ended March 31, 1995
and 1994 are computed based on 96,141,312 and 96,033,180 weighted average number
of shares outstanding, respectively. The effect of stock options issued under
the 1987 Executive Long-Term Incentive Plan and the 1990 Long-Term Incentive
Plan on the computation of primary and fully diluted earnings per common share
was not material and had no effect on the reported earnings per common share.



                                     - 6 -
<PAGE>
 
NOTE G.   Supplemental Cash Flow Information

          Following is supplemental cash flow information for the three months
 ended March 31, 1995 and 1994:

<TABLE>
<CAPTION>
 
                                                 1995         1994
                                                 ----         ----
                                                 (Millions of Dollars)
<S>                                              <C>         <C> 
Notes Payable:
    Gross proceeds from issuances                $ 449       $  27
    Gross repayments                              (450)        (52)
                                                 -----       -----
    Net repayments                               $  (1)      $ (25)
                                                 =====       =====
 
Cash paid during the period for:
 
    Interest (net of amount capitalized)         $  18       $  18
                                                 =====       =====
 
    Income taxes (net of refunds)                $  15       $   -
                                                 =====       =====
 
</TABLE>

NOTE H.   Corporate Restructuring Program

          In connection with the 1994 global restructuring, approximately 130
 people will be leaving the company.  The company accrued $30 million before tax
 in the fourth quarter of 1994, consisting primarily of personnel costs (pension
 enhancements, severance and other ancillary costs) associated with the
 employment terminations.  Of the total accrued, approximately one half of such
 amount related to severance and other ancillary costs that will be paid from
 company funds within the current year. Through March 31, 1995, the activity
 related to the accrual was not significant.


NOTE I.   Long-term Supply Arrangement

          As more fully described in the December 31, 1994 consolidated
 financial statements, the company entered into a long-term, toluene di-
 isocyanate supply arrangement in January 1995.  A substantial portion of the
 initial payment of $80 million made at closing related to capacity reservation
 fees and other long-term rights and costs.  These are reported in the
 accompanying consolidated balance sheet as "Deferred charges and other assets"
 and are being amortized on a straight-line basis over the 15-year period of the
 agreement, the period of expected benefit.



                                     - 7 -
<PAGE>
 
               Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                        

Product Volumes

          Sales volumes of the company's key product, propylene oxide (PO), its
 two co-products, tertiary butyl alcohol (TBA) and styrene monomer (SM), and
 their derivatives for the first quarter 1995 and 1994 are set forth below.
 Methyl tertiary butyl ether (MTBE) is a key derivative of TBA used in
 oxygenated fuels and reformulated gasoline and as a gasoline octane additive.

<TABLE>
<CAPTION>
 
                                               1995  1994 
                                               ----  ---- 
                                                (Millions)
    <S>                                        <C>    <C>  
    PO and derivatives (pounds)                 937   943 
    TBA and derivatives (gallons)               289   238 
    SM and derivatives (pounds)                 699   620  
 
</TABLE>

The company manufactures and markets its products in three major world regions,
the Americas, Europe, and Asia Pacific.


Results of Operations

          Net Income

          Net income increased 180 percent to $126 million, or $1.31 per share,
 for the first quarter 1995 from $45 million, or $.47 per share, for the first
 quarter 1994. The 1995 improvement primarily reflected strong worldwide SM
 demand, resulting in higher SM margins and volumes, as well as higher demand
 for MTBE, resulting in higher overall MTBE margins and volumes.

          Revenues and Gross Profit

          Revenues increased 51 percent to $1,141 million in the first quarter
 1995 from $757 million in the first quarter 1994 primarily due to higher sales
 prices across all product lines. Gross profit of $297 million in the first
 quarter 1995 increased $127 million from $170 million in the 1994 first
 quarter. Overall gross profit margins were 26.0 percent in 1995 compared to
 22.5 percent in 1994. The 1995 increases in revenues and gross profit primarily
 reflected higher SM sales prices, margins and volumes, higher U.S. MTBE prices
 and margins, as well as higher MTBE volumes.

          PO and Derivatives

          PO and derivatives margins in the first quarter 1995 increased
 slightly versus the prior year period as benefits from a weaker U.S. dollar and
 generally higher sales prices offset increases in propylene feedstock costs. PO
 and derivatives volumes in the first quarter 1995 decreased  slightly versus
 the first quarter 1994 as higher volumes resulting from the stronger European
 economy were offset by lower U.S. volumes. U.S. volumes were affected by the
 mild winter, which reduced demand for propylene glycol(PG)-based deicers, and
 the startup of the Texaco PO/MTBE plant, which increased industry supplies of
 PO and PG.



                                     - 8 -
<PAGE>
 
          TBA and Derivatives

          TBA and derivatives margins in the first quarter 1995 increased versus
 the first quarter 1994. Higher MTBE prices and margins in the U.S. more than
 offset lower margins in Europe where increases in methanol and butane feedstock
 costs were only partly recovered through higher MTBE prices. TBA and
 derivatives volumes increased 21 percent in the first quarter 1995 versus the
 first quarter 1994 primarily due to increased U.S. demand for MTBE in
 reformulated gasoline, resulting from implementation of the second phase of the
 Clean Air Act.

          On June 30, 1994, the Environmental Protection Agency (EPA)
 promulgated regulations under the Clean Air Act requiring that 15 percent in
 1995, and 30 percent thereafter, of the oxygenate content in reformulated
 gasoline be supplied by oxygenates such as ethanol and ethyl tertiary butyl
 ether (ETBE), which are derived from renewable feedstocks. ETBE uses ethanol as
 a feedstock. In September, 1994, the U.S. Court of Appeals for the District of
 Columbia granted a temporary stay of the EPA regulations. The regulations, if
 implemented, may, in the long term, decrease demand for MTBE and increase
 demand for other oxygenates derived from renewable feedstocks, including ETBE.
 The company is capable of producing both MTBE and ETBE.

          The company is responding through public education and other steps to
 consumer concerns about the potential health and performance effects resulting
 from the widespread use of fuel oxygenates, particularly MTBE. Extensive
 studies of MTBE over the past 20 years support the product's continued use in
 gasoline.  The EPA approves of the use of MTBE to meet Clean Air Act standards
 and reduce air emissions.  Nonetheless, additional studies on MTBE and
 reformulated gasoline are presently being conducted.


          SM and Derivatives

          SM and derivatives margins improved significantly in the first quarter
 1995 versus the first quarter 1994 reflecting increased worldwide SM demand and
 tighter SM supplies due to planned maintenance turnarounds at other producers'
 plants. SM and derivatives volumes in the first quarter 1995 increased 13
 percent over the first quarter 1994 due to higher U.S. merchant and export
 sales, reflecting the increased worldwide demand and tighter supply.


          Other

          The company expects its 1995 effective tax rate to be 36.5 percent
 compared to a 40.7 percent tax rate used in the first quarter 1994 and a final
 1994 effective tax rate of 35.3 percent. The higher estimated tax rate used in
 the first quarter 1994 was primarily due to lower estimated foreign source
 earnings.



 Liquidity and Capital Resources

          As of March 31, 1995, the company had $105 million in cash and cash
 equivalents compared with $144 million at December 31, 1994. The Consolidated
 Statement of Cash Flows for the quarter ended March 31, 1995 shows that net
 cash flows provided by operating activities were $134 million, whereas net cash
 flows used by investment and financing activities were $102 million and $71
 million, respectively.


                                     - 9 -
<PAGE>
 
          Investment activities for the first quarter 1995 included capital
 expenditures of $28 million. The company has approved a 1995 budget for plant
 and equipment of $195 million, which includes environmental, health and safety
 projects as well as low-cost debottlenecks. As more fully described in the
 company's consolidated financial statements for the year ended December 31,
 1994, the company entered into a long-term, toluene di-isocyanate supply
 arrangement in January 1995. A substantial portion of the initial $80 million
 payment made at closing related to capacity reservation fees and other long-
 term rights and costs. These are reported in the accompanying consolidated
 balance sheet as "Deferred charges and other assets" and are being amortized on
 a straight-line basis over the 15-year period of the agreement, the period of
 expected benefit.

          The company paid dividends of $.625 per share, totalling $60 million,
 in the first quarter 1995. On April 14, 1995, the Board of Directors declared a
 dividend of $.625 per share on the company's common stock, payable June 2,
 1995.

          It is expected that future cash requirements for capital expenditures,
 dividends and debt repayments will be met by cash generated from operating
 activities and additional borrowing.



Statement of Financial Accounting Standards Not Yet Adopted

          In March 1995, the Financial Accounting Standards Board issued
 Statement of Financial Accounting Standards (SFAS) No. 121, "Accounting for the
 Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of."
 SFAS No. 121 requires companies to adopt its provisions for fiscal years
 beginning after December 15, 1995.  The provisions of SFAS No. 121 require the
 company to review its long-lived assets for impairment on an exception basis
 whenever events or changes in circumstances indicate that the carrying amount
 of the assets may not be recoverable through future cash flows.  An impairment
 loss is indicated when the carrying amount exceeds such cash flows. The company
 is in the process of evaluating the provisions of SFAS No. 121.



                                     - 10 -
<PAGE>
 
                          PART II.  OTHER INFORMATION


                                        
Item 1.   Legal Proceedings

          Reference is made to the disclosure on page 9 of the company's 1994
 Form 10-K Report regarding the Turtle Bayou, Texas CERCLA Site.  Upon
 finalization of the consent decree, it is expected that the Order will be
 rescinded with respect to the company.

Item 6.   Exhibits and Reports on Form 8-K

 (a) Exhibits:

     27  Financial Data Schedule for the three months ended March 31, 1995.

 (b) Reports on Form 8-K:

     None



                                     - 11 -
<PAGE>
 
                                   SIGNATURE

          Pursuant to the requirements of the Securities Exchange Act of 1934,
 the registrant has duly caused this report to be signed on its behalf by the
 undersigned thereunto duly authorized.



                                                 ARCO CHEMICAL COMPANY
                                                     (Registrant)


                                                 /s/ John A. Shaw
                                                 -----------------------------  
                                                          (Signature)

                                                 John A. Shaw
                                                 Vice President
                                                 and Controller
                                                 (Duly Authorized Officer and
                                                 Chief Accounting Officer)
 


 Dated:  April 28, 1995



                                     - 12 -
<PAGE>
 
                                 EXHIBIT INDEX


                                        
 Exhibit
 Number                            Description
 -------                           -----------


    27             Financial Data Schedule for the three months
                   ended March 31, 1995

<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               MAR-31-1995
<CASH>                                             105
<SECURITIES>                                         0
<RECEIVABLES>                                      693
<ALLOWANCES>                                         0
<INVENTORY>                                        400
<CURRENT-ASSETS>                                 1,238
<PP&E>                                           3,675
<DEPRECIATION>                                   1,396
<TOTAL-ASSETS>                                   3,977
<CURRENT-LIABILITIES>                              634
<BONDS>                                            906
<COMMON>                                           100
                                0
                                          0
<OTHER-SE>                                       1,666
<TOTAL-LIABILITY-AND-EQUITY>                     3,977
<SALES>                                          1,141
<TOTAL-REVENUES>                                 1,141
<CGS>                                              844
<TOTAL-COSTS>                                      844
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  22
<INCOME-PRETAX>                                    198
<INCOME-TAX>                                        72
<INCOME-CONTINUING>                                126
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       126
<EPS-PRIMARY>                                     1.31
<EPS-DILUTED>                                     1.31
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission